137 results
Page 4 of 7
8-K
EX-99.1
urrry72 ysj3rezclo7y
26 Jun 20
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
4:13pm
8-K
EX-1.1
jh1qi34dpzdvg8o
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
8-K
EX-99.1
wye8y04b3de5w cl
13 Apr 20
Fennec Pharmaceuticals Announces Fda Filing Acceptance and Priority Review of New Drug Application for Pedmarktm
5:09pm
8-K
EX-99.1
abhj7ln7i425qvric
5 Mar 20
Fennec Announces Issuance of U.S. Patent for Use of Pedmarktm
1:18pm
8-K
EX-99.1
6uoip1m
28 Feb 20
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
10:28am
8-K
EX-99.1
k1n9p0u2
14 Feb 20
Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
11:40am
8-K
EX-99.1
jjzizzt vvvgv
11 Feb 20
PEDMARKTM1 is Being Developed for Prevention of Cisplatin-Induced Hearing Loss in Children
2:17pm
8-K
EX-99.1
8ef3b
12 Nov 19
Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results
10:52am
8-K
EX-99.1
z2q78zgt pyj0xu
24 Sep 19
FENNEC APPOINTS JODI A. COOK, PhD TO ITS BOARD OF DIRECTORS
3:08pm
8-K
EX-99.1
mtqtzfs
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm